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ABSTRACT 
Objectives: Structural and functional changes in pulmonary vessels are prevalent at the 
initial stages of chronic obstructive pulmonary disease (COPD).  These vascular 
alterations can be assessed using cross-sectional area (CSA) of small pulmonary vessels.  
However, neither in non-COPD smokers nor in COPD patients it has been defined 
whether the structural changes of pulmonary vessels detected by paired inspiratory and 
expiratory CT scans are associated with emphysematous changes.  We quantified the 
CSA and low attenuation area (LAA) and evaluated the changes in these parameters in 
the inspiratory and expiratory phases. 
Materials and Methods: Fifty consecutive non-COPD smokers and COPD patients 
were subjected to multi detector-row CT and the percentage of vessels with a CSA less 
than 5 mm
2
 as well as the percentage LAA for total lung area (%CSA < 5, %LAA, 
respectively) were calculated.   
Results: The %CSA < 5 correlated negatively with %LAA.  The %CSA < 5 was lower 
in COPD patients with emphysema as compared with non-COPD smokers and COPD 
patients with or without mild emphysema.  In addition, the %CSA < 5 was lower in the 
no / mild emphysema subgroup as compared with non-COPD smokers.  The 
respiratory phase change of %CSA < 5 in COPD patients was greater than that in 
non-COPD smokers. 
Conclusion: The percentage of small pulmonary vessels decreased as emphysematous 
changes increase, and this decrease was observed even in patients with no / mild 
emphysema.  Furthermore, respiratory phase changes in CSA were higher in COPD 
patients than in non-COPD smokers.   
 
INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow 
limitation associated with an enhanced chronic inflammatory response of the lungs to 
noxious particles or gases, primarily caused by cigarette smoking (1, 2).  Airflow 
limitation is caused by a combination of parenchymal destruction (emphysema)-induced 
loss of elastic coil and small airway remodeling.  The pathophysiology of COPD 
depends on these factors, although their relative contributions vary from person to 
person. 
 
Although major COPD abnormalities occur in the alveolar structures, including 
peripheral airways, changes in pulmonary vessels are also an important component of 
this disease (3, 4).  In severe COPD, emphysematous destruction accompanied with 
vascular changes may result in pulmonary hypertension.  Pulmonary vessel alterations 
in COPD are characterized by wall thickening and endothelial dysfunction (5, 6).  
Recent studies have shown that these changes are observed in the early stages of COPD 
as well as in smokers with normal pulmonary function (7). 
 
The technological progress of high resolution computed tomography (HRCT) has 
made it possible to detect small units of emphysema and subsegmental bronchus as well 
as peripheral pulmonary arteries (8, 9).  Many quantitative assessments of emphysema 
or small airways have been performed.  However, few studies have focused on 
pulmonary vessels.  Recently, Matsuoka et al. proposed the cross-sectional area (CSA) 
of small pulmonary vessels as a parameter of pulmonary vessel alterations in patients 
with COPD (10-12).  They reported that in case of severe emphysema the total CSA of 
subsegmental levels correlated with the mean pulmonary arterial pressure.  These 
authors also reported a good correlation of total CSA with forced expiratory volume in 
one second / forced vital capacity (FEV1 / FVC) and FEV1 %predicted in patients with 
severe COPD (11).   However, whether these correlations are also observed in 
smokers with normal lung function and patients with early-stage COPD has not been 
defined. 
 
Emphysema volume or mean lung density in expiratory CT images has been reported 
to be a superior predictor of pulmonary function tests (PFTs) abnormalities compared to 
those in inspiratory CT images (13-15).  Yet, there has been no study comparing paired 
inspiratory and expiratory CT images with regard to CSA in patients with COPD.  
Whether CSA or the respiratory phase change of CSA differs between emphysema and 
non-emphysema phenotypes of COPD has not been established.  In this study, we 
measured CSA and low attenuation area (LAA) in paired inspiratory and expiratory CT 
scans, to see whether lung vessel involvement was associated with lung destruction or 
obstructive impairment. 
 
MATERIALS AND METHODS 
Subjects 
Fifty patients diagnosed with or suspected of having COPD were recruited at Chiba 
University Hospital from July 2009 to December 2010.  COPD was diagnosed on the 
basis of past history, physical examination and spirometric data according to the 
Japanese Respiratory Society (JRS) guidelines.  Spirometric measurements were 
performed using Fudac-60 (Fukuda Denshi; Tokyo, Japan); as recommended by the 
American Thoracic Society (ATS).  This study was approved by the ethics committee 
of Chiba University School of Medicine and all patients gave their informed consent in 
writing. 
 
MDCT scanning 
Multi detector-row CT (MDCT) was performed in the supine position with 1mm 
collimation.  All patients underwent 64-multi detector CT (Aquillion ONE, Toshiba 
Medical systems; Tokyo, Japan) at full inspiration and full expiration.  Images were 
obtained using 120 kV and 200 mA at 0.35 sec/rotation.  CT images were 
reconstructed with 0.5mm slice thickness using standard and bone algorithms. 
 
CT measurement of small pulmonary vessels 
For CSA measurements, three HRCT images were selected; (1) the level at 1cm 
above the upper margin of the aortic arch (upper lung fields), (2) 1cm below the carina 
(middle lung fields), and (3) 1cm below the right inferior pulmonary vein (lower lung 
fields).  HRCT images were analyzed using an image processing program (ImageJ 
Version 1.44, available on the Web at imagej.nih.gov/ij/download/).   
 The CSA measurements were performed according to the following steps (Figure 1).  
(1) The threshold technique was adopted with attenuation between -500 and -1024 
Hounsfield units (HU).  (2) These images were converted into binary images at a 
window level of -720 HU.  (3) The range of circularity was set from 0.9 to 1.0 using 
the "Analyze particles" function of ImageJ software.  (4) CSA was measured 
separately by the size of each vessel (less than 5 mm
2
 and 5-10 mm
2
), and the CSAs on 
the three selected CT slices were summed up. 
 
LAA measurements were performed according to the following steps.  (1) The 
threshold technique was adopted with attenuation between -500 and -1024 HU.  (2) 
These images were converted into binary images at a window level of -950 HU.  (3) 
The range of circularity was set from 0 to infinity, and the LAA was summed using the 
"Analyze particles" function of ImageJ software on each slice.  The total lung area was 
obtained using threshold values between -500 to -1024 HU.   
 
The percentage of CSA < 5 (%CSA < 5), CSA 5-10 (%CSA 5-10), and LAA (%LAA) 
in the total lung area were calculated.  For the evaluation of the difference in %CSA 
among COPD phenotypes and smokers with normal lung function (non-COPD 
smokers), COPD patients were divided into two groups according to the extent of LAA 
as follows: emphysema phenotype (%LAA ≥ 12.5%) and no / mild emphysema 
phenotype (%LAA < 12.5%) (16). 
 
Statistical analysis 
Data are expressed as mean (range).  Univariate analysis used χ2 tests for categorical 
variables and one-way analysis of variance for quantitative variables with Sheffe's test 
as a post hoc test for multiple comparisons.  Correlations of %CSA (%CSA < 5, %CSA 
5-10) with %LAA and airflow obstruction (FEV1 / FVC and FEV1 %predicted) were 
evaluated by Spearman’s rank correlation analysis.  The differences in CSA among the 
three groups, and in change of %CSA < 5 between inspiration and expiration were 
assessed by two-way analysis of variance and Tukey-Kramer test.  For all statistical 
analyses, the level of significance was set at p < 0.05.  All statistical analyses were 
performed using JMP 10.0 software (SAS institute, Cary, NC).   
 
RESULTS 
Patient characteristics and pulmonary function tests 
The characteristics and the results of PFTs of the 50 patients are summarized in Table 
1.  The number of patients with COPD in each Global Initiative for Chronic 
Obstructive Lung Disease (GOLD) stage was as follows: stage 1, n = 10; stage 2, n = 
12; stage 3, n = 13; stage 4, n = 3.  Twelve smokers with normal pulmonary function 
tests (FEV1 / FVC ≥ 0.7) were included in this study.  Non-COPD smokers and 
COPD patients with mild to moderate (stage 1 and 2) degrees of airflow limitation, 
accounted for 70% of the whole study population. 
 
Difference in %CSA < 5 among COPD phenotypes and smokers 
  Because there was a wide variation of %CSA < 5 among patients with COPD, 
the %CSA < 5 was compared among COPD phenotypes and non-COPD smokers.  
The %CSA < 5 was significantly lower in patients with the emphysema phenotype as 
compared with non-COPD smokers and patients with the no / mild emphysema 
phenotype.  In addition, the %CSA < 5 was significantly lower in patients with the no / 
mild emphysema phenotype of COPD as compared with that in non-COPD smokers 
(Figure 2).  A wide variation was observed regarding %CSA < 5 in the no / mild 
emphysema phenotype subgroup.  However, a significant correlation was observed 
between %CSA < 5 and %LAA on inspiratory images in non-COPD smokers and in the 
no / mild emphysema phenotype subgroup. 
 
Difference in %CSA 5-10 among COPD phenotypes and non-COPD smokers 
 The %CSA 5-10 was significantly lower in patients with the emphysema phenotype as 
compared with non-COPD smokers (Figure 3).  The %CSA 5-10 gradually decreased 
in relation to the severity of emphysema, however, there were no significant differences 
between patients with the no / mild emphysema phenotype and those with the 
emphysema phenotype, or between patients with the no / mild emphysema phenotype 
and non-COPD smokers. 
 
Change in %CSA < 5 from the inspiratory to the expiratory phase on CT images 
To evaluate the change in %CSA < 5 from the inspiratory to the expiratory phase, we 
calculated ∆%CSA < 5 (100 × [expiratory %CSA < 5 – inspiratory %CSA < 5] / 
inspiratory %CSA < 5).  The ∆%CSA < 5 in COPD patients, including both 
phenotypes, was greater compared with that in non-COPD smokers (Figure 4).  
∆%CSA < 5 did not differ significantly between the two COPD phenotypes.  However, 
when COPD patients were distributed according to obstructive impairment, the ∆%CSA 
< 5 in patients with stages 1 and 2 COPD was larger than in patients with stages 3 and 4 
COPD or in non-COPD smokers.  The ∆%CSA < 5 in patients with stages 3 and 4 
COPD was similar to that in non-COPD smokers (Figure 5). 
 
  We also evaluated the change in %LAA (∆%LAA) from the inspiratory to the 
expiratory phase (100 × [expiratory %LAA – inspiratory %LAA] / inspiratory %LAA).  
The ∆%LAA was greater in patients with the no / mild emphysema phenotype than in 
those with the emphysema phenotype, but in patients with the no / mild emphysema 
phenotype it was similar to that in non-COPD smokers (Figure 6). 
 
 
Correlation among %CSA < 5, %LAA and lung function 
Percentage CSA < 5, %CSA 5-10 and %LAA determined based on paired inspiratory 
and expiratory CT images are presented in Table 1.  Percentage CSA < 5 in expiration 
(0.93 ± 0.22) was significantly larger than that in inspiration (0.77 ± 0.21) (p < 0.001).  
Correlation coefficients between %CSA and %LAA or obstructive impairment are 
shown in Table 2.   
 
Percentage CSA < 5 showed a significant negative correlation with %LAA both in the 
inspiratory (r = -0.68) and expiratory phases (r = -0.59) (Figure 7), while %CSA 5-10 
showed a weak correlation (inspiratory phase; r = -0.50, expiratory phase; r = -0.41).  
Percentage CSA < 5 showed a significant correlation with FEV1 / FVC and 
FEV1 %predicted both in the inspiratory and expiratory phases.  In addition, %CSA < 
5 showed a significant correlation with V50 / V25, especially in the expiratory phase 
(table 2).   
 
DISCUSSION 
  In the present study, %CSA < 5 was lower in patients with emphysema COPD 
phenotype than in those with no / mild emphysema phenotype, and lower in these than 
in non-COPD smokers.  This suggests that the total number of small pulmonary 
vessels in lung fields decreases with the worsening of emphysematous changes, and 
that these pulmonary vessel changes may occur even in patients with mild COPD.   
On the other hands, the percentage of small pulmonary vessels of 5-10 mm
2
 were not 
clearly associated with %LAA.  Percentage CSA < 5 may include both elastic and 
muscular vessels, but would mostly reflect elastic vessels.  No pulmonary imaging 
instrument can distinguish between these two types of vessels, although secondary 
pulmonary lobular arteries with a diameter around 1 mm are easily observed on HRCT.  
Narrowing and disappearance of small airways (< 2 mm in diameter) are one of the 
characteristic findings in COPD patients (17).  The secondary lobular arteries that 
accompany small airways are included in %CSA < 5, as these vessels travel mostly 
vertically in CT slices.  Percentage CSA < 5 could serve as an index to detect changes 
in small pulmonary vessels associated with emphysematous changes or initial COPD 
changes; that is, small airway changes. 
 
  This study showed that %CSA < 5 correlated negatively with the extent of 
emphysema.  This finding is compatible with the results of a previous study, 
supporting the concept that vascular alteration in COPD is influenced by 
emphysematous changes (11).  Early studies suggested that the pulmonary vascular 
bed was destroyed by emphysematous changes in COPD patients (18, 19).  A decrease 
of %CSA < 5 in emphysematous lungs might reflect these histological changes, which 
could be detected by HRCT.  Furthermore, a decrease in %CSA < 5 might reflect 
passive vascular compression by emphysema (air trapping in lung fields) (11).  On CT 
images obtained during the expiratory phase, %CSA < 5 was higher than that found in 
the inspiratory phase.  Passive vascular compression may be partly released by 
expiration.  In the present study, ∆%LAA was lower in patients with emphysema 
phenotype than that in patients with the no / mild emphysema phenotype and in 
non-COPD smokers.  Trapped air may decrease in parallel with the decrement in total 
lung volume in patients with COPD emphysema phenotype. 
 
Percentage CSA < 5 correlated with %LAA and obstructive impairment expressed as 
FEV1 / FVC, FEV1 %predicted and V50 / V25, in the present study.  Our study 
confirmed previous findings and in addition we assessed %CSA and %LAA in 
non-COPD smokers and especially mild to moderate COPD based on paired inspiratory 
and expiratory CT images.  In both inspiratory and expiratory phases, CSA was 
similarly associated with %LAA, extent of emphysema and obstructive impairment.  It 
remains controversial whether inspiratory or expiratory CT indices are better predictors 
of COPD (14, 20).  However, some studies reported that expiratory CT images were 
superior for determining the extent of emphysema and showed better correlation with 
PFTs than inspiratory images (15, 21, 22).   
 
  In this study, ∆%CSA < 5 was defined as the percentage change from the inspiratory 
to the expiratory phase, and this index was higher in patients with early-stage (stages 1 
and 2) COPD than that in non-COPD smokers.  This suggested that there might be 
some difference in the behavior of small pulmonary vessels between early-stage COPD 
and non-COPD smokers regarding respiratory phases.  Basic science research revealed 
a role for endothelial dysfunction in COPD (23, 24), although published studies 
assessing in vivo endothelial dysfunction are few (25-27).  Barr and co-workers (27) 
reported that flow-mediated dilation of the brachial artery is a noninvasive procedure 
and measures endothelium-dependent, NO-mediated vasodilation.  The larger ∆%CSA 
< 5 found in early-stage COPD may indicate that the effects of impaired endothelial 
function are greater in patients with early-stage COPD.  Interestingly, ∆%CSA < 5 was 
lower in patients with stages 3 and 4 COPD than in those with stages 1 and 2 COPD, 
although the baseline %CSA < 5 differed between the two groups.  Progression of 
obstructive impairment can decrease respiratory phase-induced changes in small 
pulmonary vessels.  The anatomical destruction or functional disturbance of 
pulmonary vessels may partly explain the decrement of ∆%CSA < 5 in patients with 
severe COPD. 
 
  Percentage CSA < 5 showed a positive correlation with the degree of peripheral 
airway obstruction (V50 / V25).  Within the lung parenchyma, the bronchi and 
pulmonary artery branches are closely associated.  Hasegawa et al. demonstrated that 
in COPD patients the dimension of distal airways was more closely related to airflow 
limitation than that of proximal airways (28).  The positive correlation between %CSA 
< 5 and one of the indexes of peripheral airway obstruction (V50 / V25), suggests that 
small pulmonary vessels may be affected by the inflammation of these distal or 
peripheral airways. 
 
There are some limitations to this study.  First, the number of patients was relatively 
small.  Moreover, our study focused on patients with early-stage COPD and 
non-COPD smokers, since 70 % of our patients were non-COPD smokers and COPD 
with mild and moderate (stages 1 and 2) degree of airflow limitation.  Second, we used 
the same thresholds for inspiratory and expiratory CT images for LAA quantification 
and CSA measurement.  There are some studies using different thresholds for 
quantification of emphysema (21).  However, this threshold issue has been undefined, 
since other authors have used the same setting for both measurements (22).  Third, 
inspiration and expiration depend on patients' efforts.  The patients were instructed to 
expire air as much as possible and hold it at deep expiration, but the effort in inspiration 
and expiration probably differed among them.  Finally, we did not analyze the airway 
dimension in the current study, thus the relationship between airway disease and 
pulmonary vessels was not clarified.  Therefore, we distributed the COPD patients into 
no / mild emphysema phenotype and emphysema phenotype.  Further studies are 
needed to clarify the relationship between airway disease and pulmonary vessels. 
 
  In conclusion, CSA measured using paired inspiratory and expiratory MDCT 
revealed that CT images are influenced in different ways by the degree of LAA and 
obstructive impairment in non-COPD smokers and even in patients with mild to 
moderate COPD.   
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 Figure 1 
Method used to measure the cross-sectional area of small pulmonary vessels (CSA) 
employing ImageJ software.  (a) Computed tomography (CT) image of lung fields 
segmented within the threshold between -500 and -1024 Hounsfield units (HU).  (b) 
These images were converted into binary images at a window level of -720 HU.  The 
range of circularity was set from 0.9 to 1.0 using the "Analyze particles" function of the 
ImageJ software.  (c) The CSA of vessels less than 5 mm
2
 and 5-10 mm
2
 were 
measured separately on inspiratory and expiratory CT images (left: CSA < 5 on an 
inspiratory image, %CSA < 5 = 0.64; right: CSA < 5 on an expiratory image, %CSA < 5 
= 0.84 in a patient with COPD). 
 
  
  
Figure 2 
Cross-sectional area (CSA) of small pulmonary vessels less than 5 mm
2
 (%CSA < 5) 
in non-COPD patients, COPD patients with no / mild emphysema phenotype (%LAA < 
12.5) and COPD patients with emphysema phenotype (%LAA ≥ 12.5%). 
  
 Figure 3 
 Cross-sectional area (CSA) of small pulmonary vessels 5 to 10 mm
2
 (%CSA 5-10) in 
non-COPD subjects and COPD phenotypes classified by the severity of emphysema. 
  
  
Figure 4 
 Comparison of ∆%CSA < 5 (% change in CSA < 5 from inspiration to the expiration 
phase) between non-COPD smokers and COPD patients. 
  
  
Figure 5 
 Comparison of ∆%CSA < 5 (% change in CSA < 5 from inspiration to the expiration 
phase) among non-COPD smokers and COPD patients distributed according to the 
severity of obstructive impairment (stages 1 and 2 vs. stages 3 and 4). 
  
  
Figure 6 
Comparison of ∆%LAA (% change in LAA from inspiration to the expiration phase) 
among non-COPD smokers and two COPD phenotypes.   
  
  
Figure 7 
Relationship between %CSA < 5 and %LAA measured on (a) inspiratory and (b) 
expiratory phases. 
 
Table 1  Characteristics of the 50 patients. 
 
Characteristic Non-COPD smoker 
No/mild emphysema 
phenotype 
Emphysema phenotype 
Age (years) 63.3 (44–82) 71.1 (56–84) 70.7 (47–83) 
Sex (male/female) 11/1 24/1 13/0 
BMI (kg/m
2
) 23.7 (20.1–32.7) 23.1 (16.4–33.4) 20.4 (16.5–23.5) 
Smoking (pack-year) 46.2 (7.3–105) 46.1 (11–106) 46.7 (26.5–60) 
Pulmonary function tests 
VC % predicted (%) 99.5 (68.1–135.9) 98.7 (49.1–141.3) 89.9 (70.2–110.1) 
FVC (L) 3.37 (1.73–5.51) 3.05 (1.34–4.23) 2.88 (2.02–4.69) 
FEV1 (L) 2.49 (1.36–4.31) 1.81 (0.55–2.92) 1.23 (0.51–3.26) 
a
 
FEV1/FVC (%) 75.5 (70.6–85.3) 57.1 (28.2–69.9) 
a
 40.4(26.5–69.5) a,b 
FEV1% predicted (%) 85.0 (56.1–121.2) 69.1 (25.5–107.1) 46.4(25.2–83.4) 
a,b
 
V50/V25 4.18 (2.1–7.04) 3.38 (1.45–6.81) 2.06(0.77–3.36) 
a,b
 
Measurements of CT parameters 
%CSA < 5  
inspiration 0.94 (0.62–1.17) 0.78 (0.53–1.32) a 0.59(0.39–0.76) a,b 
expiration 1.04 (0.52–1.33) 0.98 (0.67–1.28) 0.73(0.34–1.18) a,b 
%CSA5–10 
inspiration 0.47 (0.31–0.70) 0.39 (0.21–0.78) 0.30 (0.15–0.40) a 
expiration 0.51 (0.24–0.85) 0.46 (0.13–0.81) 0.34(0.19–0.52) a,b 
%LAA 
inspiration 1.76 (0.10–9.34) 1.57 (0.21–7.8) 27.1(13.4–46.5) a,b 
expiration 1.03 (0–6.59) 0.48 (0.003–2.30) 22.5(7.36–52.5) a,b 
 
BMI, body mass index; VC, vital capacity; FVC, forced vital capacity, FEV1, forced expiratory volume in 1 s. Date shown as mean 
(range). 
a
 p < 0.05 vs non-COPD. 
b
 p < 0.05 vs no/mild emphysema phenotype. 
Table 2 
Spearman’s correlation coefficients for comparison between CT measurements and pulmonary function tests. 
 %LAA FEV1 / FVC FEV1 % predicted V50 / V25 
r p r p r p r p 
Insp.  
%CSA < 5 -0.68 < 0.001 0.53 < 0.001 0.37 < 0.01 0.39 < 0.01 
%CSA 5-10 -0.50 < 0.001 0.31 < 0.05 0.26 NS 0.31 < 0.05 
Exp.  
%CSA < 5 -0.59 < 0.001 0.55 < 0.001 0.45 < 0.01 0.55 < 0.001 
%CSA 5-10 -0.41 < 0.01 0.41 < 0.01 0.36 < 0.05 0.46 < 0.01 
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